| Financial Year |
March 31 2023 |
| Monetary Funds |
1,315,537,985.32 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
1,691,170,251.21 |
| Advances to Suppliers |
5,100,941.00 |
| Other Receivables |
556,454.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
10,111,998.27 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
410,066,478.92 |
| Total Current Assets |
3,505,066,090.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
14,235,000.00 |
| Long-term Equity Investment |
803,702,816.18 |
| Investment Properties |
19,142,121.09 |
| Fixed Assetes |
14,310,062,500.79 |
| Under-construction Projects |
2,520,833,642.65 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
197,848,998.83 |
| R&D expenses |
-- |
| Goodwill |
18,121,610.82 |
| Long-Term Deferred and Prepaid Expenses |
728,448.63 |
| Deferred Income Tax Assets |
17,005,642.50 |
| Other Non-Current Assets |
28,406,054.42 |
| Sub-Total of Non-Current Assets |
17,984,888,164.95 |
| Total Assets |
21,489,954,255.01 |
| Short-Term Loans |
149,030,899.64 |
| Trading Financial liabilities |
-- |
| Notes Payable |
54,346,478.01 |
| Accounts Payable |
763,076,977.27 |
| Accounts Received In Advance |
23,896.68 |
| Employee Compensation Payable |
19,122,306.75 |
| Taxes Payable |
22,677,204.06 |
| Interest Payable |
-- |
| Dividend Payable |
2,311,891.82 |
| Other payables |
332,825,268.99 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,739,060,519.86 |
| Other Current Liabilities |
2,262,545.31 |
| Sub-Total of Current Liabilities |
3,082,426,096.57 |
| Long-term Loans |
7,836,326,406.62 |
| Bonds Payable |
1,007,743,835.61 |
| Long-Term Accounts Payable |
191,151,574.72 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
6,011,260.53 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,066,864,351.39 |
| Total Liabilities |
12,149,290,447.96 |
| Paid-In Capital(Or Share Stock) |
1,600,540,535.00 |
| Capital Surplus |
4,495,382,810.54 |
| Surplus Reserve |
230,824,629.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,876,004,658.42 |
| Minority Stockholder's Interest |
1,117,826,146.46 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
8,222,837,660.59 |
| Owner's Equity（Stockholder's Equity） |
9,340,663,807.05 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,489,954,255.01 |
